We are live on ! Find out more
SC

Saturna Capital Portfolio holdings

AUM $7.13B
1-Year Est. Return 35.47%
This Fund
S&P 500
This Quarter Est. Return
-0.11%
1 Year Est. Return
+35.47%
3 Year Est. Return
+92.6%
5 Year Est. Return
+130.56%
10 Year Est. Return
+515.97%
AUM
$7.37B
AUM Growth
-$275M
Cap. Flow
-$127M
Cap. Flow %
-1.72%
Top 10 Hldgs %
47.17%
Holding
168
New
10
Increased
62
Reduced
42
Closed
11

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$20.8M
2
AVGO icon
Broadcom
AVGO
+$11M
3
KVUE icon
Kenvue
KVUE
+$8.53M
4
FERG icon
Ferguson
FERG
+$4.99M
5
UL icon
Unilever
UL
+$1.4M

Top Sells

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$109M
2
CSCO icon
Cisco
CSCO
+$17.4M
3
LLY icon
Eli Lilly
LLY
+$16.8M
4
BMY icon
Bristol-Myers Squibb
BMY
+$12.6M
5
PFE icon
Pfizer
PFE
+$9.1M

Sector Composition

Rank Sector Weight
1 Technology 50.2%
2 Healthcare 18.73%
3 Industrials 12.33%
4 Consumer Staples 6.55%
5 Consumer Discretionary 6.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SKM icon
151
SK Telecom
SKM
$11.8B
$231K ﹤0.01%
11,000
STM icon
152
STMicroelectronics
STM
$44.7B
$225K ﹤0.01%
9,000
-1,335
-13% -$35.4K
BKNG icon
153
Booking.com
BKNG
$154B
$209K ﹤0.01%
+1,050
New +$202K
FICO icon
154
Fair Isaac
FICO
$31B
$203K ﹤0.01%
+102
New +$218K
ORAN
155
DELISTED
Orange
ORAN
$197K ﹤0.01%
20,000
DVAX
156
DELISTED
Dynavax Technologies
DVAX
$174K ﹤0.01%
+13,613
New +$165K
IOVA icon
157
Iovance Biotherapeutics
IOVA
$2.1B
$152K ﹤0.01%
20,553
BMY icon
158
Bristol-Myers Squibb
BMY
$130B
-243,150
Closed -$12.6M
CRSP icon
159
CRISPR Therapeutics
CRSP
$4.68B
-9,779
Closed -$459K
ELV icon
160
Elevance Health
ELV
$83.7B
-209,939
Closed -$109M
FBIN icon
161
Fortune Brands Innovations
FBIN
$6.09B
-2,350
Closed -$210K
FROG icon
162
JFrog
FROG
$9.26B
-8,601
Closed -$250K
HLN icon
163
Haleon
HLN
$45.2B
-11,500
Closed -$122K
MCHP icon
164
Microchip Technology
MCHP
$41.1B
-2,635
Closed -$212K
MU icon
165
Micron Technology
MU
$927B
-2,175
Closed -$226K
NVEC icon
166
NVE Corp
NVEC
$564M
-3,100
Closed -$248K
OTEX icon
167
Open Text
OTEX
$6.02B
-41,440
Closed -$1.38M
VAL icon
168
Valaris
VAL
$5.16B
-13,290
Closed -$741K

Similar funds

Saturna Capital's Q4 2024 Portfolio in Review

As of Q4 2024, Saturna Capital held 168 positions worth $7.37B, down 3.6% from $7.65B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Saturna Capital's Q4 2024 filing shows 10 new, 62 increased, 42 reduced and 11 closed positions. Its largest new stake was Emerson Electric: 9,121 shares worth $1.13M. The largest sale was Elevance Health, an estimated $109M.

By sector, the portfolio is most concentrated in Technology at 50% of assets, up from 47% a quarter earlier, followed by Healthcare and Industrials.

  • Saturna Capital's largest Q4 2024 buy was Emerson Electric: 9,121 shares worth $1.13M.
  • Saturna Capital added most to NVIDIA in Q4 2024, an estimated $20.8M increase.
  • Saturna Capital's biggest Q4 2024 reduction was Cisco, cutting an estimated $17.4M.
  • Saturna Capital fully exited Elevance Health in Q4 2024, selling an estimated $109M.
  • Saturna Capital's ten largest holdings make up 47% of its $7.37B portfolio in Q4 2024.
  • Saturna Capital opened 10 new positions and closed 11 in Q4 2024.
  • Saturna Capital's portfolio value fell 3.6% quarter-over-quarter to $7.37B.

Based on Saturna Capital's 13F filing for Q4 2024, filed 7 Feb 2025.